$50,000 of JPMORGAN CHASE HOLDINGS LLC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Federal activity on tax and budget, regulatory reform and general banking, securities, housing, and general financial services issues; Credit Card Competition Act (draft proposal); H.R.1, One Big Beautiful Bill Act (P.L.119-21); FY26 Financial Services and General Government Appropriations Act (H.R.5166)."
You can find more data on corporate lobbying on Quiver Quantitative.
JPM Congressional Stock Trading
Members of Congress have traded $JPM stock 17 times in the past 6 months. Of those trades, 7 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $JPM stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 09/23, 07/02.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 07/24.
- SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 07/18.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE CLEO FIELDS purchased up to $50,000 on 06/30.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 3 purchases worth up to $45,000 on 06/17, 06/11, 06/09 and 1 sale worth up to $15,000 on 06/10.
- REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
- REPRESENTATIVE DAVID TAYLOR sold up to $15,000 on 06/11.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 05/15.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $250,000 on 05/12.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
JPM Insider Trading Activity
JPM insiders have traded $JPM stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $JPM stock by insiders over the last 6 months:
- JEREMY BARNUM (Chief Financial Officer) sold 40,014 shares for an estimated $10,034,434
- LINDA BAMMANN has made 0 purchases and 2 sales selling 19,000 shares for an estimated $5,205,471.
- MARY E. ERDOES (CEO Asset & Wealth Management) sold 14,055 shares for an estimated $3,689,940
- TROY L ROHRBAUGH (Co-CEO CIB) sold 12,500 shares for an estimated $3,288,443
- MARIANNE LAKE (CEO CCB) sold 12,274 shares for an estimated $3,278,087
- JENNIFER PIEPSZAK (Chief Operating Officer) has made 0 purchases and 2 sales selling 12,257 shares for an estimated $3,145,354.
- ASHLEY BACON (Chief Risk Officer) has made 0 purchases and 2 sales selling 10,403 shares for an estimated $2,756,627.
- DOUGLAS B PETNO (Co-CEO CIB) sold 10,141 shares for an estimated $2,706,561
- STACEY FRIEDMAN (General Counsel) has made 0 purchases and 2 sales selling 9,429 shares for an estimated $2,505,409.
- LORI A BEER (Chief Information Officer) sold 5,873 shares for an estimated $1,568,605
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
JPM Hedge Fund Activity
We have seen 2,135 institutional investors add shares of JPM stock to their portfolio, and 2,113 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 72,887,375 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $22,990,864,696
- BANK OF AMERICA CORP /DE/ added 6,287,359 shares (+13.2%) to their portfolio in Q2 2025, for an estimated $1,822,768,247
- FMR LLC removed 4,962,193 shares (-10.6%) from their portfolio in Q2 2025, for an estimated $1,438,589,372
- WELLINGTON MANAGEMENT GROUP LLP removed 3,342,908 shares (-14.0%) from their portfolio in Q2 2025, for an estimated $969,142,458
- SANDERS CAPITAL, LLC removed 3,221,878 shares (-41.5%) from their portfolio in Q2 2025, for an estimated $934,054,650
- FISHER ASSET MANAGEMENT, LLC removed 2,993,722 shares (-16.3%) from their portfolio in Q2 2025, for an estimated $867,909,945
- BARCLAYS PLC added 2,462,177 shares (+20.4%) to their portfolio in Q2 2025, for an estimated $713,809,734
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
JPM Analyst Ratings
Wall Street analysts have issued reports on $JPM in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 10/07/2025
- Evercore ISI Group issued a "Outperform" rating on 09/30/2025
- Wells Fargo issued a "Overweight" rating on 09/16/2025
- B of A Securities issued a "Buy" rating on 06/18/2025
- RBC Capital issued a "Outperform" rating on 05/20/2025
- Piper Sandler issued a "Overweight" rating on 05/20/2025
- TD Securities issued a "Buy" rating on 05/20/2025
To track analyst ratings and price targets for JPM, check out Quiver Quantitative's $JPM forecast page.
JPM Price Targets
Multiple analysts have issued price targets for $JPM recently. We have seen 13 analysts offer price targets for $JPM in the last 6 months, with a median target of $330.0.
Here are some recent targets:
- Jason Goldberg from Barclays set a target price of $342.0 on 10/15/2025
- Betsy Graseck from Morgan Stanley set a target price of $338.0 on 10/15/2025
- Erika Najarian from UBS set a target price of $350.0 on 10/07/2025
- Glenn Schorr from Evercore ISI Group set a target price of $330.0 on 09/30/2025
- John McDonald from Truist Securities set a target price of $319.0 on 09/24/2025
- Keith Horowitz from Citigroup set a target price of $325.0 on 09/24/2025
- Mike Mayo from Wells Fargo set a target price of $345.0 on 09/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
